Cowealth Medical China Co.,Ltd. operates as a medical company in China. It offers centralized procurement services for in-vitro diagnostic reagents and consumab...
China's A-share pharmaceutical industry chain continues to strengthen, with Chimin and CMC hitting the daily limit, following TJPC, YIBAI PHARMACEUTICAL, and PKU HEALTHCARE also hitting the daily limit. Previously, Huaren Health, Baheal Medical, SYPM, INNOSTIC, and HRPC, among other stocks, rose more than 5%
CMC announced that CMC Hong Kong plans to reduce its holdings by 3.98 million shares of the company through a centralized bidding method from December 24, 2025, to December 31, 2025, accounting for 0.9999% of the total share capital. As the funding needs have been met, CMC Hong Kong has decided to terminate this reduction plan early
Shanghai Stock Exchange: This week, focus monitoring will be conducted on delisted stocks such as Suwu and stocks with significant volatility like *ST A-Zenith and CMC
CMC: The suspension review has ended, and the stock will resume trading
Shanghai Stock Exchange: Key monitoring of stocks with severe abnormal fluctuations such as CMC and HSC
7 consecutive trading limits for CMC: The cumulative increase in stock price has severely deviated from the fundamentals, posing a risk of rapid decline